Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
M&T Bank
MTB
$36.6B
| $36.9M | 0.05% |
238,390
-95,280
| -29% | -$15.4M |
|
477
Grupo Aeroportuario del Pacifico
PAC
$12.8B
| $36.8M | 0.05% |
378,700
+6,200
| +2% | +$524K |
|
|
CNR
478
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $36.7M | 0.05% |
2,140,020
+118,020
| +6% | +$1.9M |
|
479
Equinix
EQIX
$105B
| $36.7M | 0.05% |
+91,570
| New | +$34.8M |
|
480
Veeco
VECO
$3.26B
| $36.6M | 0.05% |
1,226,760
-112,140
| -8% | -$3.12M |
|
|
BEAT
481
DELISTED
BioTelemetry, Inc.
BEAT
| $36.1M | 0.05% |
1,247,045
+147,745
| +13% | +$3.66M |
|
|
DD
482
DELISTED
Du Pont De Nemours E I
DD
| $36.1M | 0.05% |
+448,900
| New | +$34.9M |
|
483
Weis Markets
WMK
$1.77B
| $36M | 0.05% |
603,800
+10,000
| +2% | +$613K |
|
484
PetMed Express
PETS
$42.7M
| $36M | 0.05% |
1,786,315
+188,615
| +12% | +$3.99M |
|
485
Starbucks
SBUX
$123B
| $35.8M | 0.05% |
613,084
-1,437,000
| -70% | -$81.3M |
|
486
Dover
DOV
$28B
| $35.7M | 0.05% |
550,539
-162,171
| -23% | -$10.3M |
|
|
IMOS
487
ChipMOS TECHNOLOGIES
IMOS
$1.97B
| $35.7M | 0.05% |
1,708,517
+419,040
| +32% | +$7.89M |
|
|
TARO
488
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $35.7M | 0.05% |
306,200
-241,400
| -44% | -$26.7M |
|
489
TransUnion
TRU
$15.2B
| $35.7M | 0.05% |
930,300
+747,500
| +409% | +$26.3M |
|
490
Avery Dennison
AVY
$13.7B
| $35.5M | 0.05% |
440,300
+133,100
| +43% | +$10.3M |
|
491
Allison Transmission
ALSN
$10.1B
| $35.4M | 0.05% |
981,866
-289,734
| -23% | -$10.3M |
|
492
Black Hills Corp
BKH
$5.6B
| $35.2M | 0.05% |
530,300
+227,100
| +75% | +$14.4M |
|
|
CATM
493
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $35.2M | 0.05% |
753,000
+264,500
| +54% | +$13M |
|
|
SRC
494
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $35.2M | 0.05% |
774,011
+62,909
| +9% | +$3M |
|
495
Willis Towers Watson
WTW
$31.5B
| $35M | 0.05% |
267,020
+86,523
| +48% | +$11M |
|
496
Extreme Networks
EXTR
$3.22B
| $34.9M | 0.05% |
4,649,961
| – | – |
|
497
Northwest Bancshares
NWBI
$2.3B
| $34.8M | 0.05% |
2,068,400
+101,700
| +5% | +$1.78M |
|
498
Qualys
QLYS
$6.47B
| $34.8M | 0.05% |
917,900
+186,000
| +25% | +$6.53M |
|
499
Ituran Location and Control
ITRN
$1.11B
| $34.7M | 0.05% |
1,124,900
+92,800
| +9% | +$2.62M |
|
|
CST
500
DELISTED
CST Brands, Inc.
CST
| $34.7M | 0.05% |
720,800
+715,000
| +12,328% | +$34.5M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.